A Sign Of Future Biosimilars Litigation?

Law360, New York (December 5, 2011, 1:14 PM EST) -- On Oct. 28, 2011, the U.S. District Court for the District of Massachusetts granted plaintiffs Momenta Pharmaceuticals Inc. and Sandoz Inc.'s motion for preliminary injunction against defendants Amphastar Pharmaceuticals Inc., International Medication Systems Ltd. and Watson Pharmaceuticals Inc. See Momenta Pharmaceuticals Inc., et al. v. Amphastar Pharmaceuticals Inc., et al., No. 1:11-cv-11681-NMG (D. Mass. Oct. 28, 2011) ("Momenta opinion").

The Momenta plaintiffs had previously brought suit for infringement of Momenta's patents concerning quality-control methods for generic versions of Sanofi-Aventis' branded drug Lovenox (enoxaparin). And while the...
To view the full article, register now.